Ladenburg Thalmann Financial Services’s Paratek Pharmaceuticals, Inc. PRTK Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2019
Q4
$5K Hold
1,250
﹤0.01% 4811
2019
Q3
$5K Sell
1,250
-100
-7% -$400 ﹤0.01% 4718
2019
Q2
$5K Hold
1,350
﹤0.01% 4738
2019
Q1
$7K Buy
1,350
+1,100
+440% +$7.1K ﹤0.01% 4554
2018
Q4
$1K Sell
250
-600
-71% -$4.56K ﹤0.01% 5122
2018
Q3
$8K Hold
850
﹤0.01% 4410
2018
Q2
$11K Hold
850
﹤0.01% 4214
2018
Q1
$11K Buy
850
+250
+42% +$3.72K ﹤0.01% 4214
2017
Q4
$11K Buy
600
+200
+50% +$4.17K ﹤0.01% 4150
2017
Q3
$10K Buy
+400
New +$9.31K ﹤0.01% 4102

Other funds holding PRTK

Ladenburg Thalmann Financial Services's PRTK Position: Q4 2019 in Review

Ladenburg Thalmann Financial Services held its Paratek Pharmaceuticals, Inc. (PRTK) position steady in Q4 2019 at 1,250 shares worth $5K. The position accounts for ﹤0.01% of the portfolio, ranked #4811.

Ladenburg Thalmann Financial Services first reported a position in PRTK in Q3 2017 and has held it in 10 quarters since. The position peaked at $11K in Q2 2018. 93 funds tracked by Wall St. Rank hold PRTK as of Q4 2019.

  • Ladenburg Thalmann Financial Services held 1,250 shares of Paratek Pharmaceuticals, Inc. worth $5K as of Q4 2019.
  • Ladenburg Thalmann Financial Services left its Paratek Pharmaceuticals, Inc. share count unchanged in Q4 2019.
  • Paratek Pharmaceuticals, Inc. made up ﹤0.01% of Ladenburg Thalmann Financial Services's portfolio in Q4 2019, its #4811 holding.
  • Ladenburg Thalmann Financial Services first reported a position in Paratek Pharmaceuticals, Inc. in Q3 2017 and has held it in 10 quarters since.
  • Ladenburg Thalmann Financial Services's Paratek Pharmaceuticals, Inc. position peaked at $11K in Q2 2018.
  • 93 funds tracked by Wall St. Rank held Paratek Pharmaceuticals, Inc. as of Q4 2019.

Based on Ladenburg Thalmann Financial Services's 13F filing for Q4 2019, filed 14 Feb 2020.